First-quarter net losses for NMT Medical Inc. (NSDQ:NMTI) more than doubled on a write-down of warrants the company issued in February as part of a $5.8 million private placement.
The Boston-based cardiac implant maker posted net losses of $7.9 million, or 54 cents per share, during the three months ended March 31, compared with net losses of $3.8 million, or 29 cents per share, during the same period last year.